GOLD -ABE classification: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
GOLD, At a glance outpatient management reference for chronic obstructive pulmonary disease (CPOD), 2015 | GOLD, At a glance outpatient management reference for chronic obstructive pulmonary disease (CPOD), 2015 | ||
Agusti A et al., GOLD 2023 : Highlights for primary care, npj Primary Care Respiratory Medicine, 2023{{Lien français|Article=Classification GOLD - ABE}} | Agusti A et al., GOLD 2023 : Highlights for primary care, npj Primary Care Respiratory Medicine, 2023{{Lien français|Article=Classification GOLD - ABE}}{{Lien espagnol|Article=Clasificación GOLD - ABE}} | ||
[[Category:Pneumology]] | [[Category:Pneumology]] | ||
[[Category:Clinical tools]] | [[Category:Clinical tools]] | ||
Latest revision as of 18:46, 9 October 2023
The GOLD - ABE (Global initiative for chronic Obstructive Lung Disease ABE) classification is a clinical and spirometric severity scale for chronic obstructive pulmonary disease (COPD). Its prognostic and therapeutic implications make it widely used in routine clinical practice. Historically limited to a single GOLD grading, it has become more complex with the addition of a therapeutic grading ABCD then ABE (since 2023) to the GOLD grading, which is now limited to establishing the diagnosis. See specific chapters on COPD and respiratory function tests (RFTs).
It can be downloaded in pdf format:
Author(s)
Dr Shanan Khairi, MD
Bibliography
GOLD, At a glance outpatient management reference for chronic obstructive pulmonary disease (CPOD), 2015
Agusti A et al., GOLD 2023 : Highlights for primary care, npj Primary Care Respiratory Medicine, 2023